Healthcare Services

Flowable Hemostats Market Industry Outlook 2026–2030 Highlighting Growth Momentum And Market Trends

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Value Outlook For The Flowable Hemostats Market Through 2030?

The market for flowable hemostats has shown substantial expansion in recent years. Its value is projected to climb from $1.02 billion in 2025 to $1.1 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.8%. This growth observed in past periods can be attributed to several factors, including an increase in surgical procedure volumes, the rising adoption of sophisticated surgical instruments, the wider availability of gelatin-based hemostatic agents, the broadening of specialty surgical disciplines, and enhanced awareness of flowable hemostats among surgeons.

The flowable hemostats market is poised for significant expansion in the foreseeable future. It is forecast to achieve a valuation of $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. This anticipated growth during the forecast period is driven by factors such as an escalating demand for more efficient bleeding control, a heightened focus on improving patient safety outcomes, the increasing prevalence of minimally invasive and robotic surgical techniques, continuous innovation in bioresorbable materials, and their broadened application in emergency and trauma care settings. Prominent trends expected in this period include the expanded utilization of flowable hemostats in complex surgical procedures, a growing adoption of combination hemostatic products, an increasing need for rapid hemostasis solutions, the diversification of minimally invasive surgical applications, and an intensified emphasis on biocompatible materials.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp

Which Growth Factors Are Strengthening The Flowable Hemostats Market Landscape?

The future expansion of the flowable hemostats market is anticipated to be propelled by a rising volume of surgical interventions. This increase in surgical procedures is primarily due to an aging global demographic, which fuels the demand for age-related operations, along with advancements in technology making surgeries safer and more widely accessible. Flowable hemostats are exceptionally valuable in surgical procedures, assisting in bleeding control in areas that are difficult to reach or where traditional methods may not be effective. For instance, in June 2024, a report released by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, revealed that in 2023, the combined total of surgical and non-surgical procedures climbed by 3.4%, reaching 34.9 million, when compared to the prior year. Consequently, the growing number of surgical procedures is a significant force driving the growth of the flowable hemostats market.

What Are The Major Segment Categories Within The Flowable Hemostats Market?

The flowable hemostats market covered in this report is segmented –

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats

2) By Material: Porcine Gelatin, Bovine Gelatin

3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications

4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:

1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats

2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats

3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

What Trends Are Shaping The Flowable Hemostats Market Structure?

Leading enterprises within the flowable hemostats market are concentrating on creating surgically sophisticated hemostatic compounds, including those with no-swell capabilities, to meet the changing demands of surgical operations. This no-swell technology describes a characteristic of a hemostatic substance that inhibits its absorption of liquids and subsequent enlargement, rendering it appropriate for surgical applications where expansion might lead to difficulties. As an illustration, in January 2023, Medcura Inc., a US-based surgical technology platform, was granted Food and Drug Administration (FDA) breakthrough device designation for its LifeGel flowable technology, which manages bleeding during surgical interventions unsuitable for swelling. Medcura’s LifeGel stands as the singular and pioneering flowable hemostatic gel engineered to tackle issues unique to hemostatic swelling. This absorbable agent exhibits no swelling because it arrives fully hydrated and prepared for immediate application, potentially reducing dangers linked to swelling like nerve damage and paralysis. Furthermore, it is economically efficient, maintains antimicrobial attributes, appears relatively transparent, and demonstrates mucoadhesion to tissues, thereby presenting a more secure and efficacious method for managing hemorrhage during intricate surgical processes.

Who Are The Businesses Driving Activity In The Flowable Hemostats Market?

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Access The Complete Flowable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

Which Region Leads The Flowable Hemostats Market By Size?

North America was the largest region in the flowable hemostats market in 2025. The regions covered in the flowable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Flowable Hemostats Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20552&type=smp

Browse Through More Reports Similar to the Global Flowable Hemostats Market 2026, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Bleeding Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Cyclic Heavy Menstrual Bleeding Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cyclic-heavy-menstrual-bleeding-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795